GURIANOVA, Margarita Anatolevna et al. Interim Results of the Russian Prospective Multi-Center Clinical Trial READIT-2020 (Reduction of Tyrosine Kinase Inhibitor Doses in CML Patients, Plasma Imatinib/Nilotinib Concentrations, Sustaining Molecular Response, and Drug Toxicity). Clinical Oncohematology. Basic Research and Clinical Practice, [S. l.], v. 17, n. 4, p. 347–359, 2024. DOI: 10.21320/2500-2139-2024-17-4-347-359. Disponível em: https://bloodjournal.ru/index.php/coh/article/view/101. Acesso em: 7 nov. 2025.